港股收評：三大指數收跌，大型科技股全線回調，生物醫藥板塊走強
今日港股三大指數均收跌，恆指早盤一度轉漲，午後再次回落，收跌0.45%報25001點，國指跌0.61%報9940點。今日南下資金淨流入28.03億港元，大市成交額為1465億港元。
數據來源：Wind
盤面上，生物醫藥股漲幅居前，康希諾生物漲近10%；光伏太陽能板塊領跌，汽車股全線下挫，吉利汽車跌超6%；重型機械股、紙業股、鋼鐵股、航空股走強，中國重汽升超7%，三大航空股均漲超2%；SaaS概念股走低明顯，微盟跌逾7%。
具體來看：
生物醫藥股集體走強，啟明醫療大漲超13%，康希諾生物-B漲9.62%，諾誠健華、亞盛醫藥、康方生物等跟漲。
數據來源：富途
消息面上，康希諾生物昨日午間宣佈，已開始重組新型冠狀病毒疫苗（腺病毒5型載體，Ad5-nCoV）的III期臨牀試驗，並與Petrovax簽訂協議，將共同推進在俄羅斯進行Ad5-nCoV的三期臨牀試驗。
SaaS概念股跌幅居前，微萌集團大跌7.02%，阜博集團跌超6%，中國有贊、金山軟件、中國軟件國際等跟跌。
數據來源：富途
汽車股集體走低，其中吉利汽車大跌6.46%，長城汽車跌超4%，比亞迪、北京汽車、華晨中國等跟跌。
數據來源：富途
近期強勢的大型科技股全線回調，小米大跌7%，報23.9港元，成交額97.66億港元，最新總市值5761.75億港元。
此外，美團跌近4%，京東跌2.65%，阿里跌2.4%。
圓通速遞今日繼續走強，收漲15.94%，報1.14港元，成交額28.32億元，最新總市值34.55億港元。
頤海國際一度跌超8%，截至收盤，跌7.87%，報122.9港元，成交8.24億港元，最新總市值1287億港元。近期股價持續上漲，6月中旬以來累計漲幅超96%續創新高。根據聯交所最新權益披露資料顯示，2020年8月31日-9月1日，頤海國際遭執行董事孫勝峯在場內以每股均價126.5港元及124.8208港元合計減持20萬股，涉資約2508.17萬港元。
數據來源：Wind
港股通個股方面，泰升集團大漲14%，首程控股、重慶鋼鐵股份、華寶國際漲幅居前。中國外運大跌9.57%，小米集團-U、頤海國際、微萌集團跌幅居前。
數據來源：Wind
截至收市，南向合計淨流入15.51億元，其中港股通（滬）淨流入8046萬元，港股通（深）淨流入14.71億元。
數據來源：Wind
中州國際認為，新型肺炎疫情於全球持續，雖然環球股市於3月急挫後，曾乘歐美經濟重啟而反彈，惟各地疫情又重臨，尤其美國、印度、 南美洲，以至香港等確診數字更為顯着；另一邊，中美關係惡化更困擾市場，故暫時建議中長線投資者繼續採取保守策略。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
